Osteal Therapeutics
PrivateLast Round
Series D
Jun 5, 2024
Est. Valuation
$265M
Total Funding Raised
$110.8M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Osteal Therapeutics is a biotechnology company that develops drug-device combination products for the treatment of orthopedic infections.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Osteal Therapeutics Comparables
Compare Osteal Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ForCast Orthopedics | 81% | |
| BoneSupport Holding AB | 77% | |
| Biocomposites | 75% |
Osteal Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Jun 5, 2024 | ||||
| Series C | Sep 21, 2023 | ||||
| Series B | Mar 8, 2022 | ||||
| Series A | Apr 18, 2018 |
Key People
Founding team and executive leadership
Osteal Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| HM Venture Partners | Series D, Series C |
| Gideon Strategic Partners | Series D, Series C |
| HM Capital | Series D, Series C, Series B |
| Johnson & Johnson Innovation - JJDC, Inc. | Series C, Series B, Series D, Series A |
| Medvest Capital | Series B, Series C, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 17, 2026
Monthly visitors grew 79% MoM.
- Jun 5, 2024
$50M round led by Zimmer Biomet.
Osteal Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Osteal Therapeutics's valuation, stock price, and market status.
Is Osteal Therapeutics a public or private company?
Osteal Therapeutics is a private company.
What is the current stock price of Osteal Therapeutics?
Osteal Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Osteal Therapeutics worth (valuation)?
Valuation information for Osteal Therapeutics is not publicly available.
Can I buy Osteal Therapeutics stock?
Osteal Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Osteal Therapeutics's last funding round?
Osteal Therapeutics's most recent funding round was Series D on June 5, 2024.
Who are the main investors in Osteal Therapeutics?
Key investors in Osteal Therapeutics include HM Capital, Johnson & Johnson Innovation - JJDC, Inc..
Will Osteal Therapeutics IPO soon?
No public IPO plans have been announced for Osteal Therapeutics.
How can I track Osteal Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Osteal Therapeutics's secondary market activity and sign up for updates.